Dr. Debra D Slapper, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Alder Street, South Bend, WA 98586 Phone: 360-875-5526 Fax: 360-875-6167 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the upcoming presentation of preclinical data from the company's lead program, VB-201, at the European League Against Rheumatism Annual European Congress of Rheumatology.
Medtronic, Inc. today announced the launch of its new Midas Rex e-Institute website, an enhanced web portal for healthcare professionals to explore interactive education on surgical anatomy, surgical procedures, and technical instruction.
Nearly half (43.9%) of rheumatoid arthritis (RA) patients receiving tocilizumab 8mg/kg, in addition to ongoing methotrexate therapy experienced a 50% (ACR50) improvement in symptoms at 24 weeks and more than one fifth achieved a 70% symptom improvement, according to results of a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
Scientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans.
A new survey of American adults revealed that while most feel knowledgeable when it comes to heart health, many do not put their knowledge into practice. In fact, 81 percent of respondents reported feeling well-informed about ways to maintain heart health and almost nine out of 10 knew they could help reduce the risk of heart disease by exercising and maintaining a healthy diet.
› Verified 3 days ago